All Stories

  1. Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity

    Article • Digital Biomarkers, March 2022, Karger Publishers

    Professor Adam F Cohen

  2. Futility of current urine salbutamol doping control

    Article • British Journal of Clinical Pharmacology, June 2018, Wiley

    Professor Adam F Cohen

  3. Annotated guidance to the European Medicines Agency (EMA) guidelines and regulatory documents. A new series of the BJCP

    Article • British Journal of Clinical Pharmacology, May 2018, Wiley

    Professor Adam F Cohen

  4. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses

    Article • British Journal of Clinical Pharmacology, February 2018, Wiley

    Professor Adam F Cohen

  5. Integrating data from the IMPD/IB. A new tool for translational integration of preclinical effects.

    Article • British Journal of Clinical Pharmacology, January 2018, Wiley

    Professor Adam F Cohen

  6. Pharmacological vs . classical approaches in the design of first in man clinical drug trials

    Article • British Journal of Clinical Pharmacology, October 2017, Wiley

    Professor Adam F Cohen

  7. On authorship in a scientific journal

    Article • British Journal of Clinical Pharmacology, September 2017, Wiley

    Professor Adam F Cohen

  8. Pharmacodynamic response profiles of anxiolytic and sedative drugs

    Article • British Journal of Clinical Pharmacology, March 2017, Wiley

    Professor Adam F Cohen

  9. Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects

    Article • Pharmacology Research & Perspectives, January 2017, Wiley

    Professor Adam F Cohen

  10. Organised crime against the academic peer review system

    Article • British Journal of Clinical Pharmacology, May 2016, Wiley

    Professor Adam F Cohen, Dr Annette Gilchrist

  11. The return of the prodigal son and the extraordinary development route of antibody TGN1412 - lessons for drug development and clinical pharmacology

    Article • British Journal of Clinical Pharmacology, March 2015, Wiley

    Professor Adam F Cohen

  12. The Use of Biomarkers in Human Pharmacology (Phase I) Studies

    Article • The Annual Review of Pharmacology and Toxicology, January 2015, Annual Reviews

    Professor Adam F Cohen

  13. Van idee tot onderzoek

    Article • January 2013, Springer Science + Business Media

    Professor Adam F Cohen

  14. Re-engineering the European Union Clinical Trials Directive

    Article • The Lancet, May 2012, Elsevier

    Professor Adam F Cohen

  15. Editors' pick 2009

    Article • British Journal of Clinical Pharmacology, February 2010, Wiley

    Professor Adam F Cohen

  16. Editors' Report, November 2009

    Article • British Journal of Clinical Pharmacology, January 2010, Wiley

    Professor Adam F Cohen

  17. How it works

    Article • British Journal of Clinical Pharmacology, September 2009, Wiley

    Professor Adam F Cohen

  18. Sputum Induction Reduces Exhaled Nitric Oxide in Chronic Smokers and Non-Smokers.

    Article • April 2009, American Thoracic Society

    Professor Adam F Cohen

  19. Evaluation of Two Sputum Processing Methods Applying Sensitive Detection Techniques in Allergic Asthmatics.

    Article • April 2009, American Thoracic Society

    Professor Adam F Cohen

  20. Editors’ Report, December 2008

    Article • British Journal of Clinical Pharmacology, February 2009, Wiley

    Professor Adam F Cohen

  21. Looking back: editors' pick of 2008

    Article • British Journal of Clinical Pharmacology, January 2009, Wiley

    Professor Adam F Cohen

  22. Pharmacodynamics and Pharmacokinetics of the Novel Thrombopoietin Mimetic Peptide RWJ-800088 in Humans

    Article • Clinical Pharmacology & Therapeutics, May 2008, Springer Science + Business Media

    Professor Adam F Cohen

  23. Lessons from TGN1412 – Authors' reply

    Article • The Lancet, November 2006, Elsevier

    Professor Adam F Cohen

  24. Establishing risk of human experimentation with drugs: lessons from TGN1412

    Article • The Lancet, October 2006, Elsevier

    Professor Adam F Cohen

  25. Cns Effects of Sumatriptan and Rizatriptan in Healthy Female Volunteers

    Article • Cephalalgia, May 2002, SAGE Publications

    Professor Adam F Cohen

  26. Planning and coordinating the study

    Article • January 2000, Springer Science + Business Media

    Professor Adam F Cohen

  27. A Guide to Clinical Drug Research

    Article • January 1995, Springer Science + Business Media

    Professor Adam F Cohen

  28. The study protocol

    Article • January 1995, Springer Science + Business Media

    Professor Adam F Cohen

  29. Communicating clinical research

    Article • January 1995, Springer Science + Business Media

    Professor Adam F Cohen

  30. Facilities and equipment

    Article • January 1995, Springer Science + Business Media

    Professor Adam F Cohen

  31. Ethical considerations

    Article • January 1995, Springer Science + Business Media

    Professor Adam F Cohen

  32. A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity.

    Article • British Journal of Clinical Pharmacology, August 1993, Wiley

    Professor Adam F Cohen

  33. Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

    Article • British Journal of Clinical Pharmacology, August 1993, Wiley

    Professor Adam F Cohen

  34. A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.

    Article • British Journal of Clinical Pharmacology, July 1993, Wiley

    Professor Adam F Cohen

  35. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.

    Article • British Journal of Clinical Pharmacology, June 1993, Wiley

    Professor Adam F Cohen

  36. Good clinical practice: a question of balance [see comments]

    Article • British Journal of Clinical Pharmacology, May 1993, Wiley

    Professor Adam F Cohen

  37. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.

    Article • British Journal of Clinical Pharmacology, February 1993, Wiley

    Professor Adam F Cohen

  38. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.

    Article • British Journal of Clinical Pharmacology, February 1993, Wiley

    Professor Adam F Cohen

  39. Self-selection for personality variables among healthy volunteers.

    Article • British Journal of Clinical Pharmacology, January 1992, Wiley

    Professor Adam F Cohen

  40. The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome).

    Article • British Journal of Clinical Pharmacology, July 1989, Wiley

    Professor Adam F Cohen

  41. Rate-controlled rectal absorption enhancement of cefoxitin by co- administration of sodium salicylate or sodium octanoate in healthy volunteers.

    Article • British Journal of Clinical Pharmacology, January 1989, Wiley

    Professor Adam F Cohen

  42. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

    Article • British Journal of Clinical Pharmacology, December 1985, Wiley

    Professor Adam F Cohen